[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346162-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346162-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","hif1acsf3r-neutrophils-dominated-hypoxic-niche-induced-metabolic-reprogramming-for-neoadjuvant-therapy-resistance-in-nsclc","HIF1A+CSF3R+ neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC","","Non-small cell lung cancer (NSCLC) shows molecular heterogeneity and immune infiltration patterns that influence sensitivity and resistance, yet the microenvironmental cells and mechanisms driving neoadjuvant therapy resistance remain incompletely defined. Multicenter, multicohort multi-omics profiling and clinical data were integrated to assess therapeutic and prognostic effects of HIF1A+CSF3R+ neutrophils. Functional assays validated their roles and spatial co-localization. Region-of-interest modeling predicted progression and microenvironment composition, while drug discovery and mouse studies evaluated targeted combination strategies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/hif1acsf3r-neutrophils-dominated-hypoxic-niche-induced-metabolic-reprogramming-for-neoadjuvant-therapy-resistance-in-nsclc/346162/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/hif1acsf3r-neutrophils-dominated-hypoxic-niche-induced-metabolic-reprogramming-for-neoadjuvant-therapy-resistance-in-nsclc/346162.png","ImageObject",300,407,{"name":42,"@type":43},"Valentina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in NSCLC neoadjuvant therapy?","Question",{"text":63,"@type":64},"It investigates which microenvironmental cells and mechanisms contribute to neoadjuvant therapy resistance in NSCLC, where immune and metabolic factors are linked to treatment sensitivity and relapse.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cell subset is central to the proposed resistance mechanism?",{"text":68,"@type":64},"HIF1A+CSF3R+ neutrophils are identified as a core cell subset that forms a hypoxic immunosuppressive niche and supports glycolysis- and senescence-related metabolic reprogramming.",{"name":70,"@type":61,"acceptedAnswer":71},"How did the study evaluate potential therapeutic interventions?",{"text":72,"@type":64},"It used drug screening and computer-aided drug design to identify platycodin-D2 targeting CSF3R, then assessed combination regimens including navitoclax, platycodin-D2, and anti-PD-1 in in vivo mouse models.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346162,1790898626,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Open access  \nTo cite: Zhou Y, Liu Z, Kaysar P, et al. HIF1A+CSF3R+ neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC. Journal for ImmunoTherapy of Cancer 2026;14:e014772 . doi:10.1136/jitc-2026-014772  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[jitc-2026-014772](jitc-2026-014772)) .  \nYZ, ZL, PK, YH and YM are joint first authors.  \nAccepted 24 August 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Yueguo Li; [yli08@tmu.edu.cn](yli08@tmu.edu.cn)  \nDr Haoling Zhang;  \n[zhanghaolingedu@163.com](zhanghaolingedu@163.com)  \nDr Yongjie Xie;  \n[2335940013@qq.com](2335940013@qq.com)  \nDr Zuoyu Chen;  \n[chenzuoyu24@tmu.edu.cn](chenzuoyu24@tmu.edu.cn)  \nOriginal research  \nHIF1A + CSF3R + neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC  \nYaoyao Zhou  ,1 Ziyun Liu,2 Parhat Kaysar,2 Yuxi Han,2 Yijian Ma,2 Xiaozhou Yu,3 Bo Ni,2 Zuoyu Chen,4 Yongjie Xie,2 Haoling Zhang,5 Yueguo Li1  \nABSTRACT  \nBackground Non-small cell lung cancer (NSCLC) isone of the frequently occurring cancers characterized by molecular heterogeneity and multiple immune cell infiltration patterns, which are associated with treatment sensitivity and resistance. However, the specific microenvironmental cells and their mechanisms that lead to treatment resistance in patients need to be explored in greater depth.  \nMethods On the basis of patients receiving neoadjuvant therapy in our center, a multicenter, multicohort NSCLC spatial transcriptome, single-cell transcriptome, T-cell receptor repertoire sequencing, bulk RNA transcriptome, phosphorylated proteome, genome mutation, and clinical data were included for a comprehensive assessment of the therapeutic and prognostic impact of HIF1A+ CSF3R+ neutrophils in NSCLC. In vitro experiments validated the functional phenotype of HIF1A+ CSF3R+ neutrophils and co-localization interactions with other cellular subpopulations. Gradient boosting machine (GBM) constructed region of interest (ROI) models for evaluation. Computer-aided drug design (CADD) was used to predict targeted small molecule drugs, and in vivo mouse models were constructed to assess the effectiveness of the combination treatment regimen.  \nResults Centered on HIF1A+ CSF3R+ neutrophils, recruited exhausted T cells and stromal cells form a hypoxic niche within the tumor region, which was enriched in non-response patients. ROI composed of these specific cellular subpopulations, associated with senescence and glycolysis, accurately predicting NSCLC progression, prognosis, and microenvironment composition. CADD analysis identified that platycodin-D2 specifically targeted CSF3R, reducing HIF1A expression and inhibiting neutrophil activity. Combining navitoclax, platycodin-D2 with anti-programmed cell death protein 1 (PD-1) significantly suppressed tumor proliferation and improved the immunosuppressive microenvironment.  \nConclusion Our study emphasized the role of HIF1A+ CSF3R+ neutrophils in immunotherapeutic resistance of NSCLC, constructed a microenvironmental immune dysregulation network in a hypoxic ecological niche with HIF1A+ CSF3R+ neutrophils as the center. Platycodin-D2 specifically targeted HIF1A+ CSF3R+ neutrophils, enhancing the efficacy of anti-PD-1 therapy in NSCLC.  \nWHAT IS ALREADY KNOWN ON THIS TOPIC  \n\n| ⇒ Previous studies have demonstrated that the hypoxic tumor microenvironment, metabolic reprogramming, and neutrophil-mediated immunosuppression are critical contributors to neoadjuvant therapy resistance in non-small cell lung cancer (NSCLC) .\u003Cbr>WHAT THIS STUDY ADDS |\n| --- |\n| ⇒ However, the key neutrophil s","cbCaitW2AHiaVRub","https://ap.wps.com/l/cbCaitW2AHiaVRub","pdf",14876778,21,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# What is already known on this topic\n# What this study adds\n# How this study might affect research, practice or policy\n# Introduction","[{\"question\":\"What problem does the study address in NSCLC neoadjuvant therapy?\",\"answer\":\"It investigates which microenvironmental cells and mechanisms contribute to neoadjuvant therapy resistance in NSCLC, where immune and metabolic factors are linked to treatment sensitivity and relapse.\"},{\"question\":\"Which cell subset is central to the proposed resistance mechanism?\",\"answer\":\"HIF1A+CSF3R+ neutrophils are identified as a core cell subset that forms a hypoxic immunosuppressive niche and supports glycolysis- and senescence-related metabolic reprogramming.\"},{\"question\":\"How did the study evaluate potential therapeutic interventions?\",\"answer\":\"It used drug screening and computer-aided drug design to identify platycodin-D2 targeting CSF3R, then assessed combination regimens including navitoclax, platycodin-D2, and anti-PD-1 in in vivo mouse models.\"}]","HIF1A+CSF3R+ neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC | PDF",1790060334,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a829fdae5dbb87ba5f1cbac6891515a.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/beab02261f1d5b647b7bc0db6c6d7997.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3adc273b0633b3a242d39cc966b4fa49.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/999a68ad23db1fa9ee1dd577bcd7f7ed.webp",980,1306]